Status:
COMPLETED
Transcranial Direct Current Stimulation Treatment for Warriors Experiencing Chronic Pain
Lead Sponsor:
Emory University
Collaborating Sponsors:
Wounded Warrior Project
Conditions:
Chronic Pain
Post Traumatic Stress Disorder (PTSD)
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
The Veteran population has been known to deal with co-morbid chronic pain and PTSD. As a result, they use healthcare services at a higher rate than those Veterans with pain or PTSD alone which leads t...
Detailed Description
The Veteran population has been known to deal with co-morbid chronic pain and PTSD. As a result, they use healthcare services at a higher rate than those Veterans with pain or PTSD alone which leads t...
Eligibility Criteria
Inclusion
- Male or Female, 18 -89 years old
- Treated on site for EHVP IOP
- For long-term follow-up, must live in Georgia or Florida
- Eligible for EHVP-IOP PTSD or Unified Protocol tracks
- Willing to self-administer tDCS and complete the measures
- DVPRS pain intensity of 4 or more for most of the day at least 3 days per week
- Have an established PCP (Primary Care Provider) or pain management provider
Exclusion
- Implanted pacemaker
- Seizure Disorder
- Pregnancy, if applicable
- Any new onset of the following:
- Balance problems
- Difficulty walking
- Bladder incontinence
- Bowel incontinence
- Numbness
- Tingling
- Weakness
- Medical contraindications:
- Current use of sodium channel blockers
- Lidocaine (OTC/transdermal delivery is ok)
- Mexiletine
- Amitriptyline; other tricyclic antidepressants
- Anti-epileptic medications
- Phenytoin, carbamazepine, lamotrigine, oxcarbazepine, rufinamide, lacosamide and eslicarbazepine acetate
- Current use of calcium channel blockers
- Current use of N-Methyl-D-aspartate receptor antagonists
- Ketamine
- Dextromethorphan
- Felbamate
- History of brain surgery
- History of brain tumor
- History of seizure disorder
- History of stroke
- Intracranial metal implantation
- Adults unable to consent
- Individuals who are not yet adults
- Prisoners
- Non-English speaking
Key Trial Info
Start Date :
March 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2025
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT05254379
Start Date
March 4 2022
End Date
May 31 2025
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory Division of Psychiatry
Atlanta, Georgia, United States, 30329